ResQ Pharma, Inc.
Pharmaceuticals - Chicago, Illinois, United States
ResQ Pharma, Inc. Employees
ResQ Pharma, Inc. Details
ResQ Pharma is a research & development company. Its lead program, LipidRescue Therapy (LRT) is an antidote for various non-opiate drug overdoses and poisonings including all local anesthetics (Lidocaine, Bupivacaine, etc...), benzodiazepines and psychotherapeutics (all antidepres). The FDA recently approved Orphan Drug Designation for LRT's initial sought after indication, local anesthetic systemic toxicity (LAST). ResQ Pharma plans to file applications for market approval for both the USA and EU by the 1st quarter of 2019. In 2015, within the U.S. alone, over 23,000 people died from drug overdoses and poisonings, potentially treatable with LRT.
ResQ Pharma, Inc. Technologies
Hosting
GoDaddy Hosting